Don’t Stop Translational Research Once You Move To Clinic, US FDA Tells Sponsors

 
• By Sarah Karlin-Smith
  
Two train tracks running parallel to each other
Translational research should proceed on parallel tracks with pivotal studies for best shot in using as confirmatory evidence. • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Approval Standards

More from Pathways & Standards